BlackRock, Inc. 13D and 13G filings for Aldeyra Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-29 5:25 pm Purchase | 2023-12-31 | 13G | ALDEYRA THERAPEUTICS, INC ALDX | BlackRock Inc. BLK | 3,430,774 5.800% | 2,455,827 (+251.89%) | Filing |
| 2022-07-08 4:56 pm Sale | 2022-06-30 | 13G | ALDEYRA THERAPEUTICS, INC ALDX | BlackRock Inc. BLK | 974,947 1.700% | -2,253,864 (-69.80%) | Filing |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | ALDEYRA THERAPEUTICS, INC ALDX | BlackRock Inc. BLK | 3,228,811 5.600% | 2,745,238 (+567.70%) | Filing |